This article was published in Becker’s Hospital Review on March 17, 2026. An article in Becker’s Hospital Review highlights why Shields selected Foundation Health as its partner to build AI‑enabled…
Clinical outcomes in specialty pharmacy are more important than ever, yet many leaders still lack clear, comparable benchmarks to guide how they design, measure, and improve their programs. Leveraging data from the largest health‑system…
Specialty pharmacy outcomes, elevated at scale. Download the Full 2025 Specialty Pharmacy Outcomes Report The 5th Annual Shields Specialty Pharmacy Outcomes Report is here. Featuring results from more than 2…
See how your health system can retain specialty volume, strengthen financial performance, and improve patient outcomes with the right strategy and support. Health systems without fully integrated specialty pharmacy models…
Health systems build business cases for specialty pharmacy around predictable benefits: revenue retention, 340B optimization, and continuity of patient care. But the most significant impacts rarely appear in initial ROI…
This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.
This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.
Cancer care is complex. For patients prescribed oral oncolytics, managing side effects, staying on schedule, and coordinating care can be overwhelming. These challenges often lead to missed doses, therapy interruptions,…
Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…
This poster evaluates the cimpact of an ACP program on third party pharmacy coverage determination outcomes for specialty oncology medications prescribed from these clinics.